DK5489D0 - Anvendelse af substituerede amidforbindelser til fremstilling af farmaceutiske praeparater til behandling af haematologiske sygdomme - Google Patents
Anvendelse af substituerede amidforbindelser til fremstilling af farmaceutiske praeparater til behandling af haematologiske sygdommeInfo
- Publication number
- DK5489D0 DK5489D0 DK005489A DK5489A DK5489D0 DK 5489 D0 DK5489 D0 DK 5489D0 DK 005489 A DK005489 A DK 005489A DK 5489 A DK5489 A DK 5489A DK 5489 D0 DK5489 D0 DK 5489D0
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- treatment
- application
- pharmaceutical preparations
- haematological diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14184888A | 1988-01-11 | 1988-01-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK5489D0 true DK5489D0 (da) | 1989-01-06 |
| DK5489A DK5489A (da) | 1989-07-12 |
Family
ID=22497538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK005489A DK5489A (da) | 1988-01-11 | 1989-01-06 | Anvendelse af substituerede amidforbindelser til fremstilling af farmaceutiske praeparater til behandling af haematologiske sygdomme |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0324521A3 (da) |
| JP (1) | JPH02703A (da) |
| AU (1) | AU614012B2 (da) |
| DK (1) | DK5489A (da) |
| ZA (1) | ZA89135B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL88133A0 (en) * | 1987-10-26 | 1989-06-30 | Lilly Co Eli | N-phenylalkylbenzamide fungicides |
| DE69232003T2 (de) * | 1991-09-18 | 2002-04-25 | Glaxo Group Ltd | Benzanilidderivate als 5-HT1D-Antagonisten |
| GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| GB9119920D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| US6114357A (en) * | 1995-11-13 | 2000-09-05 | Smithkline Beecham Corporation | Hemoregulatory compounds |
| US20070208087A1 (en) | 2001-11-02 | 2007-09-06 | Sanders Virginia J | Compounds, compositions and methods for the treatment of inflammatory diseases |
| DE10142878C5 (de) * | 2001-09-03 | 2007-01-25 | W.E.T. Automotive Systems Ag | Heizelement mit Litzen-Kontakt |
| US20140005240A1 (en) | 2002-05-31 | 2014-01-02 | Alan D. Snow | Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies |
| DK2527315T3 (da) | 2002-05-31 | 2014-06-02 | Proteotech Inc | Forbindelser, præparater og fremgangsmåder til behandling af amyloide sygdomme og synukleinopatier, såsom Alzheimers sygdom, type 2-diabetes og Parkinsons sygdom |
| DE10302452B4 (de) * | 2003-01-23 | 2005-02-24 | Aventis Pharma Deutschland Gmbh | Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| PL2349263T3 (pl) | 2008-10-23 | 2014-11-28 | Vertex Pharma | Modulatory mukowiscydozowego regulatora przewodnictwa przezbłonowego |
| KR100929863B1 (ko) * | 2009-05-19 | 2009-12-04 | (주)참우엔씨 | 방수, 방폭, 내진 시공 방법 |
| CN112876384A (zh) * | 2021-01-20 | 2021-06-01 | 安阳市安林生物化工有限责任公司 | 一种除虫脲的合成工艺及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69621A0 (en) * | 1982-09-02 | 1983-12-30 | Duphar Int Res | Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives |
| JPS6133176A (ja) * | 1984-07-24 | 1986-02-17 | Ishihara Sangyo Kaisha Ltd | Ｎ−ニトロベンゾイル−ｎ’−ピリダジニルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する抗癌剤 |
| JPS6193163A (ja) * | 1984-10-12 | 1986-05-12 | Ishihara Sangyo Kaisha Ltd | Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤 |
| GR860542B (en) * | 1985-03-01 | 1986-06-25 | Duphar Int Res | Benzoyl urea derivatives having antitumor activity |
| AU594098B2 (en) * | 1985-12-11 | 1990-03-01 | Ishihara Sangyo Kaisha Ltd. | N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation |
| ES2024444B3 (es) * | 1986-03-10 | 1992-03-01 | American Cyanamid Co | Metodo para la preparacion de formulacion de pildoras gruesas de liberacion sostenida. |
| TR24034A (tr) * | 1988-02-26 | 1991-02-05 | Sumitomo Chemical Company Lmt | Benzoilurea tuerevi bunu istihsal etmek icin usul bunu ihtiva eden intektisit,bunun reaksiyon ara maddesi ve aramaddesinin istihsal etme usulu |
| EP0336888A1 (de) * | 1988-03-18 | 1989-10-11 | Ciba-Geigy Ag | Mittel zur Schädlingsbekämpfung |
| IL90266A0 (en) * | 1988-05-20 | 1989-12-15 | Ciba Geigy Ag | Benzoylphenylureas |
-
1989
- 1989-01-06 EP EP19890200030 patent/EP0324521A3/en not_active Withdrawn
- 1989-01-06 DK DK005489A patent/DK5489A/da not_active Application Discontinuation
- 1989-01-06 ZA ZA89135A patent/ZA89135B/xx unknown
- 1989-01-10 JP JP1002180A patent/JPH02703A/ja active Pending
- 1989-01-11 AU AU28408/89A patent/AU614012B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU614012B2 (en) | 1991-08-15 |
| JPH02703A (ja) | 1990-01-05 |
| ZA89135B (en) | 1989-10-25 |
| DK5489A (da) | 1989-07-12 |
| EP0324521A3 (en) | 1991-11-27 |
| EP0324521A2 (en) | 1989-07-19 |
| AU2840889A (en) | 1989-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK634787A (da) | Topiske farmaceutiske praeparater til behandling af acne | |
| DK160913C (da) | Fremgangsmaade til fremstilling af topiske farmaceutiske praeparater indeholdende ikke-steroide antiinflammatoriske forbindelser | |
| DK333788A (da) | Farmaceutisk praeparat til behandling af oedelagt bruskvaev | |
| NO168174C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser | |
| DK184890A (da) | Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme | |
| NO872551D0 (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater | |
| DK5489D0 (da) | Anvendelse af substituerede amidforbindelser til fremstilling af farmaceutiske praeparater til behandling af haematologiske sygdomme | |
| DK585985A (da) | Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af amyotrof lateralsklerose | |
| ES550808A0 (es) | Procedimiento de obtencion de preparados farmaceuticos de liberacion gradual prolongada | |
| DK280282A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider | |
| NO172539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser | |
| NO164295C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. | |
| DK51282A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater | |
| NO173185C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser | |
| DK256290A (da) | Farmaceutisk praeparat indeholdende deoxyribonucleosider til saarheling | |
| NO874200L (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater | |
| NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
| NO873680L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser. | |
| DK0458855T3 (da) | Farmaceutisk præparat til behandling af tonsillitis | |
| NO875359L (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater | |
| NO872233D0 (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater | |
| NO873423D0 (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater | |
| NO172115C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser | |
| DK500589A (da) | Farmaceutisk praeparat til behandling af lungeobstruktioner | |
| DK441987A (da) | Farmaceutisk praeparat til behandling af cerebral ischaemi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |